Page last updated: 2024-08-21

quinazolines and American Trypanosomiasis

quinazolines has been researched along with American Trypanosomiasis in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (60.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (20.00)	29.6817
2010's	1 (10.00)	24.3611
2020's	1 (10.00)	2.80

Authors

Authors	Studies
Akao, Y; Akther, T; Canan, S; Cao, Y; Chowdhury, S; Condroski, K; Engkvist, O; Francisco, A; Ghosh, S; Itono, S; Kaki, R; Kamaura, M; Kelly, JM; Kimura, C; Kogej, T; Mowbray, C; Nagaoka, K; Naito, A; Ochida, A; Pairaudeau, G; Perry, B; Radu, C; Roberts, I; Shimada, M; Shum, D; Tawaraishi, T; Watanabe, NA; Xie, H; Yonezawa, S; Yoshida, O; Yoshida, R	1
Chattopadhyay, D; Chenna, BC; Desai, A; Murugesan, S; Schormann, N; Senkovich, O; Shinkre, B; Velu, SE; Walker, K	1
Afonso, LC; Bahia, MT; Chiari, E; de Lana, M; Guedes, PM; Machado-Coelho, GL; Tafuri, WL; Urbina, JA; Veloso, VM	1
Urbina, JA	1
McCormack, JJ; Richter, WE	1
Clarke, J; Davoll, J; Elslager, EF; Werbel, LM; Worth, DF	1
Bird, OD; Clarke, J; Davies, HJ; Davoll, J; Elslager, EF; Johnson, AM	1
Bird, OD; Clarke, J; Elslager, EF; Perricone, SC; Worth, DF	1
Bayles, A; Olszewski, B; Thompson, PE	1
Bayles, A; Thompson, PE	1

Reviews

1 review(s) available for quinazolines and American Trypanosomiasis

Article	Year
Specific treatment of Chagas disease: current status and new developments. Current opinion in infectious diseases, 2001, Volume: 14, Issue:6 Topics: Chagas Disease; Cysteine Proteinase Inhibitors; Humans; Quinazolines; Triazoles	2001

Other Studies

9 other study(ies) available for quinazolines and American Trypanosomiasis

Article	Year
Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an Journal of medicinal chemistry, 2023, 01-26, Volume: 66, Issue:2 Topics: Chagas Disease; Humans; Quinazolines; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi	2023
Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase. Bioorganic & medicinal chemistry, 2010, Jun-01, Volume: 18, Issue:11 Topics: Chagas Disease; Computer Simulation; Crystallization; Crystallography, X-Ray; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Protein Binding; Quinazolines; Tetrahydrofolate Dehydrogenase; Trypanocidal Agents; Trypanosoma cruzi	2010
Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:11 Topics: Animals; Chagas Disease; Dogs; Enzyme-Linked Immunosorbent Assay; Immunoglobulin G; Monocytes; Nifurtimox; Nitroimidazoles; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Trypanocidal Agents; Trypanosoma cruzi	2004
Inhibition of mammalian dihydrofolate reductase by selected 2,4-diaminiquinazolines and related compounds. Journal of medicinal chemistry, 1974, Volume: 17, Issue:9 Topics: Animals; Chagas Disease; Diamines; Enterococcus faecalis; Folic Acid Antagonists; In Vitro Techniques; Leukemia L1210; Liver; Malaria; Mice; Plasmodium berghei; Quinazolines; Rats; Trypanosoma cruzi	1974
Folate antagonists. 3. 2,4-Diamino-6-(heterocyclic)quinazolines, a novel class of antimetabolites with potent antimalarial and antibacterial activity. Journal of medicinal chemistry, 1972, Volume: 15, Issue:8 Topics: Amines; Animals; Anti-Infective Agents; Antimalarials; Antimetabolites; Chagas Disease; Chick Embryo; Chickens; Folic Acid Antagonists; Heterocyclic Compounds; Malaria; Mice; Microbial Sensitivity Tests; Quinazolines; Structure-Activity Relationship	1972
Folate antagonists. 2. 2,4-Diamino-6-((aralkyl and (heterocyclic)methyl)amino)quinazolines, a novel class of antimetabolites of interest in drug-resistant malaria and Chagas' disease. Journal of medicinal chemistry, 1972, Volume: 15, Issue:8 Topics: Animals; Antimetabolites; Benzyl Compounds; Chagas Disease; Drug Resistance, Microbial; Folic Acid Antagonists; Haplorhini; Heterocyclic Compounds; Macaca; Malaria; Methylamines; Mice; Microbial Sensitivity Tests; Quinazolines; Schiff Bases; Structure-Activity Relationship	1972
Folate antagonists. 9. 2,4-Diamino-6-((aralkyl)alkylamino)quinazolines, a potent class of antimetabolites with prodigious antimalarial effects. Journal of medicinal chemistry, 1972, Volume: 15, Issue:11 Topics: Animals; Antimalarials; Antimetabolites; Chagas Disease; Chick Embryo; Chickens; Enterococcus faecalis; Folic Acid Antagonists; Haplorhini; Lactobacillus; Lethal Dose 50; Macaca; Malaria; Mice; Microbial Sensitivity Tests; Plasmodium berghei; Quinazolines; Structure-Activity Relationship	1972
PAM 1392 (2,4-diamino-6-(3,4-dichlorobenzylamino) quinazoline) as a chemotherapeutic agent: Plasmodium berghei, P. cynomolgi, P. Experimental parasitology, 1969, Volume: 25, Issue:1 Topics: Animals; Antimalarials; Chagas Disease; Chick Embryo; Diet; Drug Synergism; Female; Haplorhini; Leucovorin; Malaria; Male; Mice; Plasmodium malariae; Quinazolines; Sulfadiazine; Trypanosoma	1969
Effects of triaminoquinazolines against Trypanosoma cruzi in mice. The Journal of parasitology, 1970, Volume: 56, Issue:3 Topics: Animals; Antiprotozoal Agents; Chagas Disease; Mice; Quinazolines; Trypanosoma	1970